Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Inhaler Corticosteroid Device market was valued at US$ 611.2 million in 2022 and is projected to reach US$ 842.4 million by 2029, at a CAGR of 4.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Beclomethasone Dipropionate Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Inhaler Corticosteroid Device include Pfizer Inc., GlaxoSmithKline Plc, Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, AstraZeneca, F. Hoffmann-La Roche Ltd. and Amgen Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Inhaler Corticosteroid Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaler Corticosteroid Device. This report contains market size and forecasts of Inhaler Corticosteroid Device in global, including the following market information:
Global Inhaler Corticosteroid Device Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Inhaler Corticosteroid Device Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Inhaler Corticosteroid Device companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inhaler Corticosteroid Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inhaler Corticosteroid Device Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Inhaler Corticosteroid Device Market Segment Percentages, by Type, 2022 (%)
Beclomethasone Dipropionate
Budesonide
Fluticasone Inhaler Powder
Mometasone
Global Inhaler Corticosteroid Device Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Inhaler Corticosteroid Device Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Academic and Research Institutes
Global Inhaler Corticosteroid Device Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Inhaler Corticosteroid Device Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inhaler Corticosteroid Device revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Inhaler Corticosteroid Device revenues share in global market, 2022 (%)
Key companies Inhaler Corticosteroid Device sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Inhaler Corticosteroid Device sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
GlaxoSmithKline Plc
Novartis AG
Mylan NV
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim International GmbH
AstraZeneca
F. Hoffmann-La Roche Ltd.
Amgen Inc.
Aurobindo Pharma
Sumitomo Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Inhaler Corticosteroid Device, market overview.
Chapter 2: Global Inhaler Corticosteroid Device market size in revenue and volume.
Chapter 3: Detailed analysis of Inhaler Corticosteroid Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inhaler Corticosteroid Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Inhaler Corticosteroid Device capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Inhaler Corticosteroid Device Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inhaler Corticosteroid Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inhaler Corticosteroid Device Overall Market Size
2.1 Global Inhaler Corticosteroid Device Market Size: 2022 VS 2029
2.2 Global Inhaler Corticosteroid Device Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Inhaler Corticosteroid Device Sales: 2018-2029
3 Company Landscape
3.1 Top Inhaler Corticosteroid Device Players in Global Market
3.2 Top Global Inhaler Corticosteroid Device Companies Ranked by Revenue
3.3 Global Inhaler Corticosteroid Device Revenue by Companies
3.4 Global Inhaler Corticosteroid Device Sales by Companies
3.5 Global Inhaler Corticosteroid Device Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Inhaler Corticosteroid Device Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Inhaler Corticosteroid Device Product Type
3.8 Tier 1, Tier 2 and Tier 3 Inhaler Corticosteroid Device Players in Global Market
3.8.1 List of Global Tier 1 Inhaler Corticosteroid Device Companies
3.8.2 List of Global Tier 2 and Tier 3 Inhaler Corticosteroid Device Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Inhaler Corticosteroid Device Market Size Markets, 2022 & 2029
4.1.2 Beclomethasone Dipropionate
4.1.3 Budesonide
4.1.4 Fluticasone Inhaler Powder
4.1.5 Mometasone
4.2 By Type - Global Inhaler Corticosteroid Device Revenue & Forecasts
4.2.1 By Type - Global Inhaler Corticosteroid Device Revenue, 2018-2023
4.2.2 By Type - Global Inhaler Corticosteroid Device Revenue, 2024-2029
4.2.3 By Type - Global Inhaler Corticosteroid Device Revenue Market Share, 2018-2029
4.3 By Type - Global Inhaler Corticosteroid Device Sales & Forecasts
4.3.1 By Type - Global Inhaler Corticosteroid Device Sales, 2018-2023
4.3.2 By Type - Global Inhaler Corticosteroid Device Sales, 2024-2029
4.3.3 By Type - Global Inhaler Corticosteroid Device Sales Market Share, 2018-2029
4.4 By Type - Global Inhaler Corticosteroid Device Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Inhaler Corticosteroid Device Market Size, 2022 & 2029
5.1.2 Hospitals and Clinics
5.1.3 Academic and Research Institutes
5.2 By Application - Global Inhaler Corticosteroid Device Revenue & Forecasts
5.2.1 By Application - Global Inhaler Corticosteroid Device Revenue, 2018-2023
5.2.2 By Application - Global Inhaler Corticosteroid Device Revenue, 2024-2029
5.2.3 By Application - Global Inhaler Corticosteroid Device Revenue Market Share, 2018-2029
5.3 By Application - Global Inhaler Corticosteroid Device Sales & Forecasts
5.3.1 By Application - Global Inhaler Corticosteroid Device Sales, 2018-2023
5.3.2 By Application - Global Inhaler Corticosteroid Device Sales, 2024-2029
5.3.3 By Application - Global Inhaler Corticosteroid Device Sales Market Share, 2018-2029
5.4 By Application - Global Inhaler Corticosteroid Device Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Inhaler Corticosteroid Device Market Size, 2022 & 2029
6.2 By Region - Global Inhaler Corticosteroid Device Revenue & Forecasts
6.2.1 By Region - Global Inhaler Corticosteroid Device Revenue, 2018-2023
6.2.2 By Region - Global Inhaler Corticosteroid Device Revenue, 2024-2029
6.2.3 By Region - Global Inhaler Corticosteroid Device Revenue Market Share, 2018-2029
6.3 By Region - Global Inhaler Corticosteroid Device Sales & Forecasts
6.3.1 By Region - Global Inhaler Corticosteroid Device Sales, 2018-2023
6.3.2 By Region - Global Inhaler Corticosteroid Device Sales, 2024-2029
6.3.3 By Region - Global Inhaler Corticosteroid Device Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Inhaler Corticosteroid Device Revenue, 2018-2029
6.4.2 By Country - North America Inhaler Corticosteroid Device Sales, 2018-2029
6.4.3 US Inhaler Corticosteroid Device Market Size, 2018-2029
6.4.4 Canada Inhaler Corticosteroid Device Market Size, 2018-2029
6.4.5 Mexico Inhaler Corticosteroid Device Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Inhaler Corticosteroid Device Revenue, 2018-2029
6.5.2 By Country - Europe Inhaler Corticosteroid Device Sales, 2018-2029
6.5.3 Germany Inhaler Corticosteroid Device Market Size, 2018-2029
6.5.4 France Inhaler Corticosteroid Device Market Size, 2018-2029
6.5.5 U.K. Inhaler Corticosteroid Device Market Size, 2018-2029
6.5.6 Italy Inhaler Corticosteroid Device Market Size, 2018-2029
6.5.7 Russia Inhaler Corticosteroid Device Market Size, 2018-2029
6.5.8 Nordic Countries Inhaler Corticosteroid Device Market Size, 2018-2029
6.5.9 Benelux Inhaler Corticosteroid Device Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Inhaler Corticosteroid Device Revenue, 2018-2029
6.6.2 By Region - Asia Inhaler Corticosteroid Device Sales, 2018-2029
6.6.3 China Inhaler Corticosteroid Device Market Size, 2018-2029
6.6.4 Japan Inhaler Corticosteroid Device Market Size, 2018-2029
6.6.5 South Korea Inhaler Corticosteroid Device Market Size, 2018-2029
6.6.6 Southeast Asia Inhaler Corticosteroid Device Market Size, 2018-2029
6.6.7 India Inhaler Corticosteroid Device Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Inhaler Corticosteroid Device Revenue, 2018-2029
6.7.2 By Country - South America Inhaler Corticosteroid Device Sales, 2018-2029
6.7.3 Brazil Inhaler Corticosteroid Device Market Size, 2018-2029
6.7.4 Argentina Inhaler Corticosteroid Device Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Inhaler Corticosteroid Device Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Inhaler Corticosteroid Device Sales, 2018-2029
6.8.3 Turkey Inhaler Corticosteroid Device Market Size, 2018-2029
6.8.4 Israel Inhaler Corticosteroid Device Market Size, 2018-2029
6.8.5 Saudi Arabia Inhaler Corticosteroid Device Market Size, 2018-2029
6.8.6 UAE Inhaler Corticosteroid Device Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Inhaler Corticosteroid Device Major Product Offerings
7.1.4 Pfizer Inc. Inhaler Corticosteroid Device Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Inc. Key News & Latest Developments
7.2 GlaxoSmithKline Plc
7.2.1 GlaxoSmithKline Plc Company Summary
7.2.2 GlaxoSmithKline Plc Business Overview
7.2.3 GlaxoSmithKline Plc Inhaler Corticosteroid Device Major Product Offerings
7.2.4 GlaxoSmithKline Plc Inhaler Corticosteroid Device Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline Plc Key News & Latest Developments
7.3 Novartis AG
7.3.1 Novartis AG Company Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Inhaler Corticosteroid Device Major Product Offerings
7.3.4 Novartis AG Inhaler Corticosteroid Device Sales and Revenue in Global (2018-2023)
7.3.5 Novartis AG Key News & Latest Developments
7.4 Mylan NV
7.4.1 Mylan NV Company Summary
7.4.2 Mylan NV Business Overview
7.4.3 Mylan NV Inhaler Corticosteroid Device Major Product Offerings
7.4.4 Mylan NV Inhaler Corticosteroid Device Sales and Revenue in Global (2018-2023)
7.4.5 Mylan NV Key News & Latest Developments
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.5.3 Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Major Product Offerings
7.5.4 Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Sales and Revenue in Global (2018-2023)
7.5.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.6 Boehringer Ingelheim International GmbH
7.6.1 Boehringer Ingelheim International GmbH Company Summary
7.6.2 Boehringer Ingelheim International GmbH Business Overview
7.6.3 Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Major Product Offerings
7.6.4 Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Sales and Revenue in Global (2018-2023)
7.6.5 Boehringer Ingelheim International GmbH Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Inhaler Corticosteroid Device Major Product Offerings
7.7.4 AstraZeneca Inhaler Corticosteroid Device Sales and Revenue in Global (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 F. Hoffmann-La Roche Ltd.
7.8.1 F. Hoffmann-La Roche Ltd. Company Summary
7.8.2 F. Hoffmann-La Roche Ltd. Business Overview
7.8.3 F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Major Product Offerings
7.8.4 F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Sales and Revenue in Global (2018-2023)
7.8.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.9 Amgen Inc.
7.9.1 Amgen Inc. Company Summary
7.9.2 Amgen Inc. Business Overview
7.9.3 Amgen Inc. Inhaler Corticosteroid Device Major Product Offerings
7.9.4 Amgen Inc. Inhaler Corticosteroid Device Sales and Revenue in Global (2018-2023)
7.9.5 Amgen Inc. Key News & Latest Developments
7.10 Aurobindo Pharma
7.10.1 Aurobindo Pharma Company Summary
7.10.2 Aurobindo Pharma Business Overview
7.10.3 Aurobindo Pharma Inhaler Corticosteroid Device Major Product Offerings
7.10.4 Aurobindo Pharma Inhaler Corticosteroid Device Sales and Revenue in Global (2018-2023)
7.10.5 Aurobindo Pharma Key News & Latest Developments
7.11 Sumitomo Corporation
7.11.1 Sumitomo Corporation Company Summary
7.11.2 Sumitomo Corporation Inhaler Corticosteroid Device Business Overview
7.11.3 Sumitomo Corporation Inhaler Corticosteroid Device Major Product Offerings
7.11.4 Sumitomo Corporation Inhaler Corticosteroid Device Sales and Revenue in Global (2018-2023)
7.11.5 Sumitomo Corporation Key News & Latest Developments
8 Global Inhaler Corticosteroid Device Production Capacity, Analysis
8.1 Global Inhaler Corticosteroid Device Production Capacity, 2018-2029
8.2 Inhaler Corticosteroid Device Production Capacity of Key Manufacturers in Global Market
8.3 Global Inhaler Corticosteroid Device Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Inhaler Corticosteroid Device Supply Chain Analysis
10.1 Inhaler Corticosteroid Device Industry Value Chain
10.2 Inhaler Corticosteroid Device Upstream Market
10.3 Inhaler Corticosteroid Device Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Inhaler Corticosteroid Device Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
